DUSP13A and lung carcinoma: The treatment of A549 lung cancer cells with actinomycin D and nutlin-3a (A + N) induces the expression of the TMDP-L1 variant of DUSP13 dual-specificity phosphatase governed by the alternative promoter located in the intron.